Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. (2021)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s0140-6736(21)00676-0
PubMed Identifier: 33933206
Publication URI: http://europepmc.org/abstract/MED/33933206
Type: Journal Article/Review
Volume: 397
Parent Publication: Lancet (London, England)
Issue: 10285
ISSN: 0140-6736